Charles D. Hyman’s Medtronic MDT Stock Holding History

Charles D. Hyman’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,888	Closed	-$233K	–	243
2023 Q1	$233K	Sell	2,888 -108	-4%	-$8.8K	0.02%	223
2022 Q4	$233K	Hold	2,996	–	–	0.02%	215
2022 Q3	$242K	Hold	2,996	–	–	0.02%	202
2022 Q2	$269K	Buy	2,996 +1,000	+50%	+$101K	0.02%	204
2022 Q1	$221K	Hold	1,996	–	–	0.01%	231
2021 Q4	$206K	Buy	1,996 +28	+1%	+$3.24K	0.01%	231
2021 Q3	$247K	Hold	1,968	–	–	0.02%	218
2021 Q2	$244K	Sell	1,968 -22	-1%	-$2.76K	0.02%	221
2021 Q1	$235K	Sell	1,990 -54	-3%	-$6.33K	0.02%	217
2020 Q4	$239K	Sell	2,044 -1,411	-41%	-$155K	0.02%	212
2020 Q3	$359K	Buy	3,455 +100	+3%	+$10K	0.03%	165
2020 Q2	$308K	Buy	3,355 +64	+2%	+$6.14K	0.03%	172
2020 Q1	$297K	Hold	3,291	–	–	0.04%	144
2019 Q4	$373K	Buy	3,291 +826	+34%	+$90.6K	0.04%	149
2019 Q3	$268K	Hold	2,465	–	–	0.03%	161
2019 Q2	$240K	Buy	2,465 +200	+9%	+$18.3K	0.03%	170
2019 Q1	$206K	Buy	+2,265	New	+$203K	0.02%	177

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Charles D. Hyman's MDT Position: Q2 2023 in Review

Charles D. Hyman sold out of Medtronic (MDT) in Q2 2023, closing a stake of 2,888 shares — an estimated $233K sold.

Charles D. Hyman first reported a position in MDT in Q1 2019 and held it in 17 quarters. The position peaked at $373K in Q4 2019. 2,057 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

Charles D. Hyman reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
Charles D. Hyman sold 2,888 Medtronic shares in Q2 2023, an estimated $233K.
Charles D. Hyman first reported a position in Medtronic in Q1 2019 and held it in 17 quarters.
Charles D. Hyman's Medtronic position peaked at $373K in Q4 2019.
2,057 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Charles D. Hyman's 13F filing for Q2 2023, filed 8 Aug 2023.